Cambridge Trust’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8
Closed -$1K 830
2022
Q3
$1K Sell
8
-992
-99% -$73.7K ﹤0.01% 812
2022
Q2
$77K Hold
1,000
﹤0.01% 426
2022
Q1
$87K Hold
1,000
﹤0.01% 452
2021
Q4
$78K Buy
+1,000
New +$76.4K ﹤0.01% 459
2018
Q1
Sell
-10,676
Closed -$585K 254
2017
Q4
$585K Sell
10,676
-557
-5% -$32.3K 0.04% 170
2017
Q3
$722K Buy
11,233
+1,171
+12% +$79.9K 0.05% 147
2017
Q2
$722K Buy
10,062
+6,464
+180% +$450K 0.05% 142
2017
Q1
$240K Buy
+3,598
New +$234K 0.02% 247

Other funds holding HSIC

Cambridge Trust's HSIC Position: Q4 2022 in Review

Cambridge Trust sold out of Henry Schein (HSIC) in Q4 2022, closing a stake of 8 shares — an estimated $1K sold.

Cambridge Trust first reported a position in HSIC in Q1 2017 and held it in 8 quarters. The position peaked at $722K in Q3 2017. 585 funds tracked by Wall St. Rank hold HSIC as of Q4 2022.

  • Cambridge Trust reported no remaining Henry Schein position as of Q4 2022 after selling out during the quarter.
  • Cambridge Trust sold 8 Henry Schein shares in Q4 2022, an estimated $1K.
  • Cambridge Trust first reported a position in Henry Schein in Q1 2017 and held it in 8 quarters.
  • Cambridge Trust's Henry Schein position peaked at $722K in Q3 2017.
  • 585 funds tracked by Wall St. Rank held Henry Schein as of Q4 2022.

Based on Cambridge Trust's 13F filing for Q4 2022, filed 10 Jan 2023.